Cyclandelate

环扁桃酯

Report date: 2023/03/01 20:00:22
NME

Base Information

Drug NameCyclandelate
Drug Alias Name杏仁酸三甲环己酯CiclandelatoCyclandelatum环扁桃脂环扁桃酸酯 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsPeripheral VasospasmEndarteritisIntracranial Arteriosclerosis +[7] 
Global Approved IndicationsPeripheral VasospasmEndarteritisIntracranial Arteriosclerosis +[7] 
Approved Indications in ChinaPeripheral VasospasmEndarteritisIntracranial Arteriosclerosis +[7] 
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Siyao Pharmaceuticals Co Ltd
Inactive CompaniesWyeth-Ayerst Pharmaceuticals Inc
Active IndicationsPeripheral VasospasmEndarteritisIntracranial Arteriosclerosis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeC04AX01
Related LinksWikipediaDrugBankKEGG